Cidara Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Cidara Therapeutics, Inc. Grants Stock Options and RSUs to New Employee New Employee Receives Stock Options and RSUs Cidara Therapeutics, Inc., a biotechnology company focused on developing drug-Fc conjugate immunotherapies, recently announced that the Compensation Committee of its Board of Directors has granted Dipesh Bhatt, a new employee, a non-qualified stock option award and restricted…